Researchers find nanodiamonds could improve effectiveness of breast cancer treatment
UCLA researchers and collaborators have developed a potentially more effective treatment for "triple-negative" breast cancer that uses nanoscale, diamond-like particles called nanodiamonds. Nanodiamonds are between 4 and 6 nanometers in diameter and are shaped like tiny soccer balls. Byproducts of conventional mining and refining operations, the particles can form clusters following drug binding and have the ability to precisely deliver cancer drugs to tumors, significantly improving the drugs' desired effect. UCLA is home to the Jonsson Comprehensive Cancer Center. The research team included contributors from the NanoCarbon Research Institute in Nagano, Japan and UC San Francisco, home of the Helen Diller Family Comprehensive Cancer Center.
Among the research institutions NCI funds across the United States, it currently designates 67 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.